Actively Recruiting

Phase 1
Phase 2
All Genders
NCT05821959

Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss

Led by Akouos, Inc. · Updated on 2026-03-04

22

Participants Needed

9

Research Sites

263 weeks

Total Duration

On this page

Sponsors

A

Akouos, Inc.

Lead Sponsor

E

Eli Lilly and Company

Collaborating Sponsor

AI-Summary

What this Trial Is About

Part A of this trial will evaluate the safety and tolerability of a single surgical administration procedure in one or both ear(s) with one of two dose levels of AAVAnc80-hOTOF and will evaluate the Akouos Delivery Device, together with the Precision Delivery Mechanism, to safely achieve the intended product performance.

CONDITIONS

Official Title

Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants may be of any age, based on Cohort Criteria
  • At least two mutations in the otoferlin gene
  • Clinical presentation of profound bilateral sensorineural hearing loss as assessed by ABR
  • Preserved distortion product otoacoustic emissions (DPOAEs)
  • Able and willing to comply with all study requirements, including willingness to participate in a separate long term follow-up study after completion of this trial
Not Eligible

You will not qualify if you...

  • Persistent ear infections, anatomic or other abnormalities of the ear, and/or medical conditions that would contraindicate undergoing surgery, anesthesia, and/or administration of investigational gene therapy
  • Cochlear Implant(s) in the ear(s) to receive AAVAnc80-hOTOF
  • Prior participation in a clinical trial with an investigational drug, within six months prior to administration, or any prior participation in a gene therapy clinical trial

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

University of California, San Francisco Benioff Children's Hospital

San Francisco, California, United States, 94158

Actively Recruiting

2

University of Iowa

Iowa City, Iowa, United States, 52242

Actively Recruiting

3

Boston Children's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

4

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229

Actively Recruiting

5

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19146

Actively Recruiting

6

Vanderbilt Bill Wilkerson Center

Nashville, Tennessee, United States, 37232

Actively Recruiting

7

The Hospital for Sick Children Jaina.negandhi@sickkids.ca +1 (416) 813 6683

Toronto, Ontario, Canada, M5G 1X8

Actively Recruiting

8

National Taiwan University Hospital

Taipei, Taiwan, 100

Actively Recruiting

9

University College London

London, United Kingdom, United Kingdom, NW1 2PG

Actively Recruiting

Loading map...

Research Team

A

Akouos Clinical Trials

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss | DecenTrialz